<DOC>
	<DOCNO>NCT01404598</DOCNO>
	<brief_summary>This study perform 2 part conduct parallel : Part 1 ( conduct 16 healthy subject ) : Administration naproxcinod 750 mg naproxen 500 mg twice day ( bid ) 7 day The main aim study part ass pharmacokinetic profile ( i.e . absorption , distribution , metabolism elimination drug administration ) nitrate ( metabolite naproxcinod ) present plasma , saliva urine oral administration naproxcinod 750 mg bid 7 day naproxen 500 mg bid 7 day reference . Part 2 ( conduct 8 healthy subject ) : Administration single dose naproxcinod 3000 mg . The main aim study part ass pharmacokinetic profile ( i.e . absorption , distribution , metabolism elimination drug administration ) Gamma-Hydroxybutyric Acid ( GHB ) , compound result transformation naproxcinod , oral administration single supratherapeutic dose 3000 mg .</brief_summary>
	<brief_title>Pharmacokinetics Study : Determination Naproxcinod Its Metabolites After Oral Administration Male</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Naproxen-n-butyl nitrate</mesh_term>
	<criteria>1 . 1 . Healthy , non smoker male subject age 18 45 year ( inclusive ) . 2 . Body Mass Index ( BMI ) 18 30 kg/m² ( inclusive ) body weight ( BW ) ≥ 50 kg . 3 . Normal physical examination ( non clinically significant abnormality ) , judge investigator . 4 . Normal electrocardiogram ( ECG ) ( 12lead ) , ( non clinically significant abnormality ) , judge Investigator . 5 . Supine Systolic Blood Pressure ( SBP ) 100 139 mmHg ( inclusive ) Diastolic Blood Pressure ( DBP ) 50 89 mmHg ( inclusive ) ( mean 3 measurement ) . 6 . Supine Heart Rate ( HR ) 45 90 bpm ( inclusive ) . 7 . Oral body temperature ( BT ) 36 37.5°C ( inclusive ) . 8 . Subject must able understand write information sheet informed consent comply study requirement . 9 . Subject must provide write , date sign informed consent prior study procedure . 1 . History hypersensitivity reaction ( asthma , rhinitis , urticaria ) aspirin , naproxen non steroidal antiinflammatory drug ( NSAIDs ) ; hypersensitivity contraindication organic nitrate drug ; Lproline . 2 . History clinically relevant gastrointestinal ( gastritis gastric ulcer ) , respiratory , psychiatric , neurologic , kidney , liver , cardiac disease , bleed disorder , disease/condition abnormal physical finding may interfere study objective , judge Investigator . 3 . After 1 minute stand position , drop 20 mmHg SBP 10 mmHg DBP compare supine position ( mean 3 measurement ) clinical manifestation postural hypotension . 4 . Any clinically significant abnormal laboratory value , include creatinine clearance ≤ 80 mL/min calculate CockcroftGault formula . 5 . Seropositivity HBs Ag , HCV Ab , HIV 1 HIV 2 Ab . 6 . Any history alcohol drug abuse , addiction within last 2 year prior enrollment . 7 . Positive drug screening ( opiate , cannabinoids , cocaine , methadone , amphetamine , barbiturate , ecstasy ) . 8 . Positive alcohol cotinine test . 9 . Donation blood , plasma platelet within 3 month prior Screening visit donation plan 3 month follow study . 10 . Regular consumption grapefruit juice beverage contain xanthine base ( coffee , tea , cola : 5 cup glass day ) . 11 . Current smoker smoke history &lt; 6 month . 12 . Current participation participation within 3 month prior Screening visit , another investigational drug device study , previous enrolment present study . 13 . Chronic use drug ( prescription counter [ OTC ] ) within 4 week prior enrollment ( single use medication paracetamol headache allow , except week enrollment ) . 14 . Use antioxidant vitamin supplement within 1 week prior enrollment . 15 . Use mouthwash toothpaste contain chlorhexidine within 1 week prior randomization ( applicable study Part 1 ) . 16 . In custody due administrative legal decision , tutelage , admit sanitary social institution . 17 . Any direct indirect involvement study conduct staff site family link study site staff .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>